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Glucocerebrosidase (GBA1) mutations are associated with Gaucher disease (GD), an autosomal recessive disorder caused by functional
deficiency of glucocerebrosidase (GBA), a lysosomal enzyme that hydrolyzes glucosylceramide to ceramide and glucose. Neuronopathic
forms of GD can be associated with rapid neurological decline (Type II) or manifest as a chronic form (Type III) with a wide spectrum of
neurological signs. Furthermore, there is now a well-established link between GBA1 mutations and Parkinson’s disease (PD), with
heterozygote mutations in GBA1 considered the commonest genetic defect in PD. Here we describe a novelDrosophilamodel of GD that
lacks the two fly GBA1 orthologs. This knock-out model recapitulates the main features of GD at the cellular level with severe lysosomal
defects and accumulation of glucosylceramide in the fly brain.We also demonstrate a block in autophagy flux in associationwith reduced
lifespan, age-dependent locomotor deficits and accumulation of autophagy substrates in dGBA-deficient fly brains. Furthermore,mech-
anistic target of rapamycin (mTOR) signaling is downregulated in dGBA knock-out flies, with a concomitant upregulation ofMitf gene
expression, the fly ortholog of mammalian TFEB, likely as a compensatory response to the autophagy block. Moreover, the mTOR
inhibitor rapamycin is able to partially ameliorate the lifespan, locomotor, and oxidative stress phenotypes. Together, our results
demonstrate that thisdGBA1-deficient flymodel is auseful platform for the further studyof the role of lysosomal-autophagic impairment
and the potential therapeutic benefits of rapamycin in neuronopathic GD. These results also have important implications for the role of
autophagy and mTOR signaling in GBA1-associated PD.
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Introduction
Homozygousmutations in the glucocerebrosidase gene (GBA1) can
cause Gaucher disease (GD), the commonest lysosomal storage dis-
order. GBA1 encodes glucocerebrosidase (GBA, also known as glu-
cosylceramidase [GCase]), whichmediates the lysosomal hydrolysis
of glucosylceramide to form ceramide and glucose. Loss of GBA
activity leads to lysosomal accumulation of glucosylceramide and its
nonacylated analog glucosylsphingosine in a number of cell types,
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Significance Statement
We developed a Drosophila model of neuronopathic GD by knocking-out the fly orthologs of the GBA1 gene, demonstrating
abnormal lysosomal pathology in the fly brain. Functioning lysosomes are required for autophagosome-lysosomal fusion in the
autophagy pathway. We show in vivo that autophagy is impaired in dGBA-deficient fly brains. In response, mechanistic target of
rapamycin (mTOR) activity is downregulated in dGBA-deficient flies and rapamycin ameliorates the lifespan, locomotor, and
oxidative stress phenotypes. dGBA knock-out flies also display an upregulation of the Drosophila ortholog of mammalian TFEB,
Mitf, a response that is unable to overcome the autophagy block. Together, our results suggest that rapamycinmay have potential
benefits in the treatment of GD, as well as PD linked to GBA1mutations.
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including macrophages and neurons, giving rise to the visceral and
neurological manifestations of GD, respectively (Cox, 2010). GD is
classified into threeclinical subtypesbasedontheabsence(TypeI)or
presence (Types II and III) of neurological involvement. Type II, or
acute neuronopathic GD, is rare but results in rapidly progressive
neurologicaldecline,withawide spectrumofclinical signsanddeath
in infancy or early childhood. Type III, or chronic neuronopathic
GD, is amore slowlyprogressivedisorderwithneurological features,
including eye movement abnormalities, myoclonic epilepsy, ataxia,
and dementia (Sidransky, 2004). There are currently no therapies
available that target the neuronal pathology associated with GD be-
cause existing treatments, such as recombinant enzyme replacement
therapy, fail to permeate the blood–brain barrier (Cox, 2010).
As well as causing GD, heterozygous GBA1 mutations are
now well-established genetic risk factors for PD and other sy-
nucleinopathies, characterized by the presence of intraneuronal
aggregates called Lewy bodies (LBs), predominantly containing
-synuclein as well as ubiquitin (Shults, 2006). Both loss-of-
function and gain-of-function hypotheses have been put forward
to explain howmutations inGBA1 lead to lysosomal dysfunction
and neurodegeneration, and there is mounting evidence in sup-
port of the loss of GBA function hypothesis (Kinghorn, 2011).
Lysosomal dysfunction in GD has far-reaching implications, not
only for the degradation of -synuclein, but also for the au-
tophagic degradation of other superfluous or damaged cellular
material and organelles, as the fusion of lysosomes with autopha-
gosomes is a critical step in the autophagic pathway (Ravikumar
et al., 2010). The process of macroautophagy can be divided into
key stages, including initiation, elongation, and maturation of
autophagosomes, followed by the fusion with lysosomes.
In keepingwith the importance of lysosomes in the autophagy
pathway, it was recently shown in macrophages and induced
pluripotent stem cell (iPSC)-derived neuronal cells from GD pa-
tients that autophagy is impaired (Awad et al., 2015; Aflaki et al.,
2016). Furthermore, this defect in autophagy was shown to trig-
ger inflammasome activation and the production of inflamma-
tory cytokines (Aflaki et al., 2016). Moreover, Osellame et al.
(2013) demonstrated that there is accumulation of dysfunctional
and fragmented mitochondria in a neuronopathic mouse model
of GD, thought to be secondary to autophagic and proteasomal
defects.
To further understand the mechanisms linking loss of GBA
activity to neurodegeneration in neuronopathic GD, and also
to determine whether autophagy plays a role in neurons in
vivo, we developed a novelDrosophilamodel that lacks the two
GBA1 orthologs, dGBA1a and dGBA1b. The fruit fly has
proven to be a useful model system for studying neurodegen-
erative diseases (Kinghorn et al., 2015) and lysosomal storage
disorders, including those affecting the nervous system, such
as neuronal ceroid lipofuscionoses (Myllykangas et al., 2005;
Hindle et al., 2011). It is therefore a useful model for studying
the mechanisms of pathogenesis of GD as well as the role of
GBA1 in neurodegeneration.
The dGBAknock-out flies proved to be faithfulmodels of GD,
with significant lysosomal dysfunction and buildup of the dGBA
substrate, glucosylceramide, in the fly brain. Furthermore, there
was significant neuronal autophagy impairment, which was as-
sociated with reduced survival and age-dependent locomotor ab-
normalities. At the cellular level, we demonstrated accumulation
of p62 and polyubiquitinated proteins, both of which accumulate
to form LBs in PD (Zatloukal et al., 2002), in addition to mito-
chondrial abnormalities. Moreover, dGBA-deficient flies dis-
played decreased mechanistic target of rapamycin (mTOR)
signaling with a reduction in p70 S6 kinase (S6K) phosphoryla-
tion, and the mTOR inhibitor rapamycin was able to partially
ameliorate the neurodegenerative phenotypes. Our results thus
show an important role of autophagy and mTOR signaling in
GD, and provide a useful model for the further study of patho-
genic mechanisms downstream of lysosomal dysfunction.
Materials andMethods
Fly stocks and husbandry. All fly strains used were backcrossed at least 6
generations into the w1118 background to obtain isogenic lines. All fly
stocks were maintained at 25°C on a 12:12 h light: dark cycle at constant
humidity on a standard sugar-yeast medium (15 g/L-1 agar, 50 g/L-1
sugar, 100 gl-1 autolyzed yeast, 3g/L nipagin, and 3ml/L propionic acid).
For all experiments, flies were raised at a controlled density on standard
sugar-yeast medium in 200 ml bottles.
Generation of dGBA1a and dGBA1b mutants by ends-out homologous
recombination. The genes encoding dGBA1a (CG31148) and dGBA1b
(CG31414) are located in close proximity onDrosophila chromosome 3,
separated by the CG31413 gene (see Fig. 1A). We generated specific mu-
tants for dGBA1a, dGBA1b and a dGBA1a and dGBA1b double-mutant,
without affecting the coding sequence of CG31413 by ends-out homol-
ogous recombination (Gong and Golic, 2004). dGBA1a was mutated by
replacing the whole ORF with a whitehs marker gene. dGBA1b was mu-
tated by introducing a stop codon and a subsequent frame shift mutation
12 bp downstream of the predicted ATG start codon. In addition, an
EcoRV restriction site was introduced to allow PCR screening of the
introduced mutations. To clone the donor construct for homologous
recombination, 4 kb of 5 and 3 flanking sequences of the dGBA1a
gene were cloned into the pBluescript II SK vector (Stratagene) by ET
recombination using BAC clone CH321–50J5 (BACPAC Resource Cen-
ter, Oakland, California) as template and primers SOL474/475 and
SOL476/477 for the 5 and 3 arms, respectively. Mutations in the 3 arm
were introduced using the QuikChange site-directed mutagenesis kit
(Agilent Technologies) and primers SOL482/483. Both 5 and 3 homol-
ogous arms were subcloned into the pW25 vector (Gong and Golic,
2004) and full-length sequenced. pW25 was obtained from theDrosoph-
ila Genomics Resource Centre. The dGBA donor construct was trans-
formed into the germline of Drosophila melanogaster by P-element-
mediated germ line transformation using the Best Gene Drosophila
Embryo Injection Service. Crosses for ends-out homologous recombina-
tion were performed according to the rapid targeting scheme (Gong and
Golic, 2004). Subsequently, the whitehs marker gene was genetically
mapped and homologous recombination events were identified by PCR.
Point mutations introduced into dGBA1b were identified by PCR with
primers SOL484 and SOL485 and subsequent digestion with EcoRV,
which results in two specific DNA fragments of 120 and 193 bp from the
uncut 313 bp wild-type DNA fragment. Oligonucleotide primers used
for cloning and genotyping are listed in Table 1.
qRT-PCR. Total RNA was extracted from 25 heads or 25 thoraces and
abdomens of 6-d-old adult flies per sample using Trizol (Invitrogen) and
further purified over an RNeasy Mini column (QIAGEN) with on-
column DNase digestion. cDNA was prepared from 2.5 g RNA using
the SuperScript Vil cDNA synthesis kit (Invitrogen). qRT-PCR data were
performed with TaqMan primers (Applied Biosystems) in a 7900HT
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real-time PCR system (Applied Biosystems). The TaqMan primers used
were as follows: Dm02150554_m1 for dGBA1b, Dm02143806_g1 for
dGBA1a, Dm02150538_s1 for CG31413, and a custom-made probe
against Rpl32. For each sample, 4 biological replicates and 4 technical
replicates were used. Relative expression was calculated using the CT
method and Rpl32 as normalization control.
For assessment ofMitf andAtg8a gene expression levels, total RNAwas
extracted from 20–25 fly heads per sample using TRIzol (Invitrogen)
according to the manufacturer’s instructions. Then 5 g of total RNA
was subjected to DNA digestion using DNase I (Ambion), immediately
followed by reverse transcription using the SuperScript II system (Invit-
rogen) with oligo(dT) primers. qPCR was performed using the PRISM
7000 sequence-detection system (Applied Biosystems) and SYBR Green
(Invitrogen) by following the manufacturer’s instructions. Each sample
was analyzed in duplicate, and values are the mean of the 3 or 4 indepen-
dent biological repeats. The primers used were as follows: atg8, ATTCC
ACCAACATCGGCTAC and GCCATGCCGTAAACATTCTC;Mitf, GC
GTTCTTCTTCAGGGATTG and ACTTACGCTCGGCGAAATAG; and
RP49, ATCGGTTACGGATCGAACAA and GACAATCTCCTTGCG
CTTCT.
Lifespan, climbing, and fecundity analyses. The survival, climbing, and
fecundity assayswere performed as previously described (Kinghorn et al.,
2015). For the lifespan experiments, 150 female flies (unless otherwise
stated) were housed in groups of 15 and the flies were transferred every
2–3 d onto fresh food and the number of dead flies recorded.
Feeding assay (proboscis extension). Feeding rates of flies were mea-
sured using a proboscis-extension assay in undisturbed conditions as
previously described (Wong et al., 2009). Briefly, flies were housed in
groups of 5 per vial and kept undisturbed for 24 h before recording
observation. Feeding rate was scored by a brief but continuous observa-
tion for at least 1 h of the number of flies actively extending their probos-
cis on the fly medium. Observation recordings were made blindly.
Feeding ability was calculated by the number of feeding events divided by
the number of flies in the vial over the time periodmeasured and then by
averaging this for all of the vials per genotype.
Stress experiments and rapamycin treatment. For all stress assays, flies
were reared and housed as for lifespan experiments, and oxidative
stress and starvation assays were performed as previously described
(Kinghorn et al., 2015). Rapamycin (LC Laboratories) was dissolved
in 100% ethanol to give a 50 mM stock concentration. It was then
added to the standard fly medium to give the desired final concentra-
tion. Equivalent volumes of vehicle were supplemented to the me-
dium to compensate for dilution.
Measurement of dGBA activity. dGBA activity was measured using a
similar method to that previously described (Davis et al., 2016). Briefly,
20 fly heads of each genotype were homogenized and debris cleared by
centrifugation. Lysates (7.5 g protein) were mixed with 0.1 M sodium
acetate, pH 4.5, and 5 mM 4-methyllumbelliferyl--D-glucopyranoside
and incubated at 37°C. The reaction was stopped with 0.25 M glycine
buffer, pH 10.4, and fluorescence measured on fluorescent plate reader
(excitation, 360 nm; emission, 460 nm). dGBA activity was also mea-
sured in the presence of the inhibitor conduritol--epoxide (100 M)
and dGBA activity calculated as total GBA activity minus CBE-sensitive
GBA activity and expressed as pmol/h/mg protein. Approximately 50%
of the total dGBA activity was abolished by incubation with conduritol-
-epoxide in w1118 control flies.
Measurement of glucosylceramide levels. Fly heads (n 70) were analyzed
for glucosylceramide accumulation. The substratewas extracted in 500l of
chloroform/methanol (2:1 v/v) containing 80 g/ml of d4-C16:0-glucosyl-
ceramide internal standard, which was synthesized in house (Mills et al.,
2005). The samples were shaken for 30min at room temperature before the
addition of 100l of PBS for phase separation.After a 10min centrifugation
at 16,000 g, upper and lower phases were collected and 5 l of each was
injected into the ultra-performance liquid chromatography-tandem mass
spectrometry system. Synthetic glucosylceramide standard (Matreya) was
also analyzed to confirm analyte identity.
The samples were injected onto Waters ACQUITY UPLC system op-
erated in partial loop mode and separated on Waters ACQUITY UPLC
BEHC18 column (130Å, 1.7m, 2.1mm 50mm) under the following
gradient conditions: 0.00–0.20¡ 80% A; 0.20–5.00¡ 0.1% A; 5.00–
9.00¡ 0.1%A; 9.01–11.00¡ 80%A, wheremobile Phase A was ddH2O
[0.1% FA] and Phase Bwasmethanol. Column and sample temperatures
were kept at 40°C and 10°C, respectively. Weak wash solvent was ddH2O
(0.1% FA), and strong wash solvent was acetonitrile: methanol:isopro-
panol:ddH2O (1:1:1:1 v/v). The eluting analytes were detected on a Wa-
ters XEVO TQ-S triple quadrupole mass spectrometer, which was
equipped with the electrospray ion source and operated in MRM and
positive ion mode with the tune page parameters set to achieve the max-
imum sensitivity for glycosphingolipids as described previously (Auray-
Blais et al., 2015). The data were processed with MassLynx version 4.1.
Measurement of lysosomal enzymes. Twenty flies were homogenized in
RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 1% (v/v) NP-40, 1%
(w/v) sodium deoxycholate, 0.1% (w/v) SDS, protease inhibitor mix-
ture) with a micro-pestle. Debris was pelleted at 17, 000 g and protein
concentration of the supernatant was determined using the protein BCA
kit (Pierce). -Hexosaminidase activity (10g protein) wasmeasured in
McIlvaine citrate buffer, pH 4.2, with 2 mM 4-methylumbelliferyl-N-
acetyl-glucosamide substrate. -Galactosidase activity (10 g protein)
was measured in McIlvaine citrate buffer, pH 4.1, with 0.25 mM
4-methylumbelliferyl--D-galactopyransoside substrate. Both enzyme
assays were incubated at 37°C for 30 min and the reaction stopped by
addition of 0.25 M glycine, pH 10.4. Fluorescent product was measured
using a plate reader (excitation, 340 nm; emission, 460 nm) and com-
pared against 1 nmol 4-methyllumbelliferone standard.
Triacylglyceride and ATP assays. Levels of triacylglyceride (TAG) in
adult females were measured using the Triglyceride Infinity Reagent
(Thermo Scientific) and normalized to total body protein using a BCA
assay (Sigma). The ATP concentration of whole female flies was deter-
mined using the ATP Bioluminescence Assay Kit HS II (Roche) as pre-
viously described (Kinghorn et al., 2015).
Table 1. The oligonucleotide primers used for cloning and genotyping in the generation of the dGBA knockout flies
Name Gene Sequence RS Comment
SOL474 GBA1a TTCGTAAACAATTTATTTTTCCGATAAAATTCGAATCTCCTATTATTAAACGTACGcacaacatacgagccggaagcata BsiWI ET Rec
SOL475 GBA1a CTCCAGTTGCGTTTTGCCAAAAGAACCAGGTGTCAATCAGGTGGCAGCGTGGCGCGCCatgtgcgcggaacccctatttg AscI ET Rec
SOL476 GBA1a AACATGTCTTTATTTAATTTTTTGTTTTGTTTAGAAAAAATAAGTTTTCAGCATGCcacaacatacgagccggaagcata SphI ET Rec
SOL477 GBA1a CGCTCCTCCCGCAACAATTCGCTGAACTACTTGGATGGCCTAGCTGTTCAGCGGCCGCatgtgcgcggaacccctatttg NotI ET Rec
SOL482 GBA1b ATGCCAGATATCTAGTACACCACTGCTTGG
SOL483 GBA1b CCAAGCAGTGGTGTACTAGATATCTGGCAT
SOL484 GBA1b ATTCGCCGGTCCGGCTGCTT
SOL485 GBA1b CTGCAATGCGTTTCATTTGAGG
SOL804 CG31468 TAATCTACGCCCAGCCCACTTG
SOL846 CG31468 ACGCTGCCACCTGATTGACA
SOL847 GBA1a ATGGGAAAAATGTTCGCCAGC
SOL848 GBA1a CTGTACAGCAGAGTGTGAATGG
SOL850 CG31413 CATCAGTGGCAGTTTACCAGTC
SOL851 CG31413 AAGCAGCCGGACCGGCGAAT
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Antibodies andWestern blotting. For Atg8Western blotting, 10 to 15 fly
headsor5headlessbodieswerehomogenized in2Laemmli loadingbuffer
(100mMTris 6.8, 20%glycerol, 4%SDS)containing5%-mercaptoethanol
and then boiled for 5 min. Approximately 40 g of protein extract was
loaded per lane. Proteins were separated on SDS polyacrylamide gels and
transferred to anitrocellulosemembrane. ForubiquitinWesternblots, 12 fly
heads per sample were homogenized in Triton-X buffer (1% Triton-X, 10
mM NEM, 50 m MG132, Complete Mini protease inhibitors, Roche, in
PBS). After centrifugation, the insoluble pellet was resuspended in SDS buf-
fer (2% SDS, 10 mMNEM, 50 mMG132, complete mini protease inhibi-
tors, Roche, 50mMTris, pH 7.4), centrifuged, and the supernatant collected
as the insoluble sample for Western blot. Proteins were separated on 4%–
12% NuPage Bis-Tris gels (Invitrogen) and transferred to a PVDF mem-
brane. The membranes were then blocked in 5% BSA in TBST (TBS with
0.05%Tween20) for 1 h at room temperature, afterwhich theywere probed
with primary antibodies diluted in 5%BSA in TBST overnight at 4°C. Blots
were developed using the ECL detection system. The following primary an-
tibodies were used: -actin (Abcam, #ab1801; 1:5000), mouse anti-poly-
ubiquitinated proteins (clone FK2, Millipore, 1:1000) and anti-Atg8 (1:
1000) (Castillo-Quan et al., 2016).
For detection of S6K and tS6K protein levels, 15 fly heads in each
sample were prepared by homogenization in 2  SDS Laemmli sample
buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl, pH 6.8, 200 mM DTT
with bromophenol blue), and boiled at 95°C for 5 min. Samples were
separated on precast 4%–12% Invitrogen Bis-Tris gels (NP0322) and
blotted onto nitrocellulose paper in Tris-glycine buffer supplemented
with 10% ethanol. They were then blocked as above, and the primary
antibodies used were anti-phosphorylated S6K anti-phospho-Thr398-
S6K (Cell Signaling Technology, #9209, 1:1000), anti-total-S6K (1:1000)
(Sofola-Adesakin et al., 2014). The appropriate secondary antibodies
(Abcam) were diluted 1:10,000 in 5% BSA in TBST for 1 h at room
temperature. Bands were visualized with Luminata Forte (Millipore).
All blots were imaged with ImageQuant LAS4000 (GE Healthcare
Life Science). Quantification was performed using the ImageJ pro-
gram (National Institutes of Health).
Immunohistochemistry, LysoTracker, confocal imaging, and quantification.
For immunohistochemistry, adult brains were dissected in PBS and imme-
diately fixed in cold 4% PFA (v/v) for 20 min at room temperature. After
fixation, the samples were washed in PBT (PBS containing 0.3% Triton
X-100, v/v) four times for 20min then blocked in PBT containing 10%BSA
(PBT-BSA) for 2 h at 20°C-30°C. For primary antibody treatment, samples
were incubated in PBT-BSA containing the primary antibody for 3 d at 4°C.
After primary antibody incubation, brains were washed in PBT, four times
for20minat20°C-30°C, then incubated inPBT-BSAcontaining the second-
ary antibody for 24 h at 4°C. Brains were washed four times with PBT for 20
min at 20°C-30°C. Brains were finally mounted in Vectashield containing
DAPI overnight (Vector Laboratories). Antibodies were used at the follow-
ing dilutions: rabbit anti-Ref(2)P (Abcam) 1:200; mouse anti-
polyubiquitinated proteins (FK2, Millipore) 1:200; mouse anti-Bruchpilot
(DSHB antibody nc82), 1:100; secondary goat anti-rabbit AlexaFluor-568
1:250, and secondary goat-anti-mouse AlexaFluor-488 1:250.
For Ref(2)P and ubiquitin staining, image stacks of specimens were
obtained on a Zeiss LSM700 confocal microscope using a 10 objective
for whole-brain imaging. Stacks of 7.25M Z distance and 14 images per
stack were taken. Images were quantified using ImageJ software. Briefly,
confocal stacks were merged into a single plane by using the maximum
projection function. A region of each central brain wasmanually selected
(200 m high, 100 mwide) from the dorsal to the ventral aspect of the
brain. Thresholds were then set for p62/Ref(2)P and ubiquitin, and the
area above threshold within this region was measured.
ForBruchpilot staining, imagestackswereobtainedusinga40objective
in the region encompassing the ventral edge of the antennal lobe and dorsal
edge of the subesophageal ganglion. Stacks of 1.00 M Z distance and 11
images per stack were taken. Images were quantified using ImageJ software.
Briefly, confocal stacks weremerged into a single plane by using the average
projection function. Two regions of each image were manually selected (10
mhigh, 10mwide), one in the center of the antennal lobe region andone
in the center of the suboesphageal ganglion region, by anobserver blinded to
genotype. Themean intensity of Bruchpilot staining was thenmeasured for
each region of interest.
For LysoTracker staining, adult brains were dissected in PBS and im-
mediately transferred to a solution of PBS with 1 M LysoTracker Red
DND-99 (Invitrogen) and 1MDAPI. Brains were mounted on slides in
this solution and imaged within 15 min of dissection on a Zeiss LSM700
confocalmicroscope using a 40 objective. For each replicate within the
experiment, one control and onemutant brain were imaged side by side,
with identical microscope settings and images taken from the same re-
gion of the subesophageal ganglion for each brain. Images were quanti-
fied using ImageJ software, by setting a threshold for LysoTracker and
measuring the area above threshold.
Electronmicroscopy of fly brains and image analysis.The flies were decap-
itated and the proboscis removed to allow penetration of the fixative.
They were then processed and visualized using previously described
methods (Kinghorn et al., 2015). Cross-sectional mitochondrial and
rhabdomere areas were measured manually using ImageJ software.
Statistical analyses.Survival experimentswereanalyzedusing log rank test.
Single comparisonswere analyzed using the Student’s t test.Other datawere
tested by ANOVA, and planned comparisons of means were made using
Tukey-Kramer HSD test. Statistical analyses were performed using Excel,
GraphPad Prism, or JMP software version 9 (SAS Institute).
Results
Knock-out of theDrosophila orthologs of GBA1 using
homologous recombination
Drosophilamelanogasterhas twoorthologsof thehumanGBA1gene,
CG31148 andCG31414, whichwe refer to as dGBA1a and dGBA1b,
respectively. These two genes are found on the same chromosome,
separated by the CG31413 gene (Fig. 1A), and show differential
tissue expression. dGBA1b is expressed in the adult brain, albeit at
low levels, as well as moderately expressed in the adult fat body.
dGBA1a is predominantly expressed in the adult fly digestive system
and shows no expression in the adult brain (Flyatlas) (Robinson et
al., 2013). To study the function of the dGBA1 genes, we pro-
duced loss-of-function mutants lacking dGBA1a (dGBA1a/),
dGBA1b (dGBA1b/), or double-mutants lacking both genes
(dGBA1a,b/) using ends-out homologous recombination. The
complete open reading frame of dGBA1a was knocked out by ho-
mologous recombination, whereas dGBA1b expression was dis-
rupted by the introduction of a stop codon and a frame shift 12b
downstream of the putative ATG start codon (Fig. 1A; for more
details, seeMaterials andMethods). Deletion of dGBA1a and integ-
rity of theCG31413 genewere confirmed by PCR on genomicDNA
(Fig. 1B). Furthermore, introduction of specific point mutations
within the dGBA1b gene were verified by PCR (Fig. 1C) and se-
quencing.To testwhether thesemutations affected expressionof the
dGBAgenes and the interjacentCG31413gene,wemeasuredmRNA
transcript levels by qRT-PCR data in female heads and bodies for
dGBA1b (Fig. 1D), in female bodies for dGBA1a (Fig. 1E), and in
male bodies for CG31413 (Fig. 1F). The latter gene is specifically
expressed inmale accessory glands (Flyatlas) (Robinson et al., 2013).
dGBA1b transcript levelswere barely detected in dGBA1b/ single-
mutant and dGBA1a,b/double-mutant flies (Fig. 1D), suggesting
that the introduced point mutations affect the stability of the
dGBA1b transcript. dGBA1a expression was absent from
dGBA1a/ single-mutant and GBA1a,b/ double-mutant flies
(Fig. 1E) and CG31413 expression was slightly reduced in
dGBA1a,b/ double-mutants (Fig. 1F). Thus, the qRT-PCR data
suggest that both dGBA1a/and dGBA1b/ are loss-of-function
alleles for the respective dGBA genes, with the single mutations not
affecting expression of the CG31413 gene, and the doublemutation
very slightly reducing it. Knock-out of dGBA1a, dGBA1b, or both
genes was not associated with any gross changes in body size or
obvious differences in morphology (data not shown). In keeping
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with the expression of dGBA1b, and not dGBA1a, in the fly brain,
dGBAactivity levelswere decreased by 95% in dGBA1b/ fly heads
and were undetectable in the heads of dGBA1a,b/ flies. Con-
versely, the levels of dGBA activity in dGBA1a/ fly headswere not
statistically different from that of controls, consistent with its pre-
dominant expression within the fly midgut (Fig. 1G).
Flies lacking dGBA displayed reduced lifespan and
progressive age-dependent locomotor deficits
The lifespan of flies lacking dGBA1a (dGBA1a/), dGBA1b
(dGBA1b/) or both dGBA1 genes (dGBA1a,b/) was assessed.
dGBA1b/ flies displayed reduced survival compared with control
flies. However, dGBA1a/ flies, which lack the dGBA isoform ex-
Figure 1. Generation of flies lacking the dGBA1a and dGBA1b genes. A, Schematic view of the dGBA1 gene locus. dGBA1a and dGBA1b are located in close proximity separated by the CG31413
gene, the function of which is unknown. Gray bars represent donor constructs for ends-out homologous recombination. Gaps between gray bars indicate genomic regions replaced by a whitehs
marker gene. Black boxes represent coding parts of exons. White boxes represent noncoding regions. dGBA1awas mutated by introduction of a stop codon and a frame shift 12 kb downstream of
the ATG start codon. Black bars A–D represent genomic regions PCR amplified in B, C. B, PCR on genomic DNA of dGBA1b/, dGBA1a/, dGBA1a, b/mutants andw1118 control flies. C, PCR
verification of point mutations in dGBA1bmutants. An EcoRV restriction site accompanied the introduced stop codon and frame shift mutation. Top, Undigested PCR product. Bottom, PCR product
restrictedwith EcoRV. A specific double band is apparent only in dGBAb/ and dGBA1a, b/mutants.D–F, Quantitative real-timePCRwith probes directed against dGBA1b (D), dGBA1a (E), and
CG31413 (F ). Total RNA was isolated from female heads (left) and bodies (right) (D), female bodies (E), and male bodies (F ). Tissue and gender were chosen corresponding to the endogenous
expression of the respective gene.D–F, **p 0.01 (one-way ANOVAwith Dunnett’s test relative tow1118 controls). ***p 0.001 (one-way ANOVAwith Dunnett’s test relative tow1118 controls).
G, dGBA activity in fly heads was decreased by95% in dGBA1b/ flies (**p 0.01) and was undetectable in dGBA1a,b/ flies (***p 0.006). Conversely, the dGBA activity measured in
dGBA1a/ fly heads was not significantly different from that of controls ( p 0.39).
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pressed mainly in the digestive system, showed a significantly in-
creased survival comparedwith control flies (Fig. 2A), and this trend
was seen using 4 additional dGBA1a null mutant fly lines (Fig. 2B).
Interestingly, double-mutantdGBA1a,b/ flies displayed a lifespan
that was similar to that of the single dGBA1b knock-out line (Fig.
2A), suggesting that the detrimental effects of dGBA1bdeficiency on
lifespan cannot be reversed by the prolongevity effects of
dGBA1a knock-out. Given that GBA1 mutations are usually
found in the heterozygous state in PD and other synucleinopa-
thies, we also assessed dGBA1b and dGBA1a heterozygote
knock-out flies (dGBA1b/ and dGBA1a/) and found that
the lifespans of these flies were not significantly different from
those of controls (Fig. 2C).
In keeping with the lifespan phenotypes, dGBA1b/ and
dGBA1a,b/ flies, which lack the dGBA isoform expressed in
the brain, also displayed progressive age-dependent locomo-
tor deficits, with the climbing ability of dGBA1b/ and
dGBA1a,b/ flies in response to light tapping falling below
that of controls at older ages (Fig. 2D). Knock-out of dGBA1a,
despite its prolongevity effects, did not have any significant
effect on climbing ability over time compared with control
flies (Fig. 2E). Therefore, because loss of dGBA1a was not
associated with any lifespan defect or change in locomotor
ability, and has no expression in the adult brain, we concen-
trated on studying the dGBA1b/ and dGBA1a,b/ flies in
the subsequent experiments.
We also assessed the fecundity of dGBA1b/ and
dGBA1a,b/ female flies as a furthermeasure of healthspan. The
number of eggs laid per female significantly declined with age
comparedwith age-matched control flies, and day 30 nullmutant
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Figure 2. Lack of dGBA activity led to reduced survival and locomotor deficits.A, dGBA1b/ and dGBA1a,b/ female flies had significantly reduced lifespan comparedwithw1118 control flies
( p 3 1039 and p 7 1027). Furthermore, dGBA1a/ flies displayed a significant lifespan extension compared with control flies ( p 8 1052). B, This lifespan extension was
consistent using a further 4 independent dGBA1a/ lines (all p 	 6  1012, n  150 flies per genotype). C, Flies heterozygous for dGBA1b or both dGBA1 genes (dGBA1b/ and
dGBA1a,b/) did not display a lifespanphenotype ( p0.69 andp0.33).D,dGBA1b/ anddGBA1a,b/ flies showedanage-dependent reduction in climbing ability comparedwithw1118
control flies ( p 0.0001 and p 0.0004; n 45 flies per genotype, 3 repeats each). E, The climbing ability of dGBA1a/ flies was indistinguishable from that of controls ( p 0.38). F, The
fecundity of dGBA1b/ and dGBA1a,b/ flies was significantly reduced at day 20 compared with age-matched control flies. ***p 3 106 . ***p 2 105. They were almost
completely infertile at day 30, whereas
20% of the control flies were still able to lay eggs.
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Figure 3. Loss of dGBA activity resulted in lipid defects and substrate accumulation in fly brains. A, Mass spectroscopic analysis revealed an7-fold increase in accumulation of the
dGBA substrate, glucosylceramide, in the heads (n 70) of 25-d-old dGBA1b/ compared with age-matched w1118 control flies. **p 0.01. The isoforms that were predominantly
elevated were C16:0, C18:0, and C20:0. B, Similar results were seen in dGBA1a,b/ fly heads (n  70 heads per sample, 3 technical repeats). ***p  0.0008. C, There was no
age-dependent decrease in hexosaminidase (HEX) activity or (D) -galactosidase (-GAL) activity in dGBA1b/ fly heads. There was a significant increase in -GAL activity in older
25-d-old dGBA1b/ fly heads compared with age-matched w1118 control flies. ***p 2 105. Data are the mean SEM of three independent experiments. E, The 25-d-old
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dGBA1b and the double-mutant dGBA1a,b/ flies were almost
completely infertile (Fig. 2F).
Knock-out of dGBA resulted in changes in lipid metabolism
and accumulation of glucosylceramide
We next assessed whether knock-out of dGBA activity in the
fly is associated with accumulation of its substrate, glucosyl-
ceramide. Indeed, using lipid mass spectrometry, we found
that dGBA1b/ and dGBA1a,b/ flies displayed significant
accumulation of glycosylceramide in their heads, whereas the
heads of w1118 control flies contained very little glycosylcer-
amide (Fig. 3A,B). Furthermore, the predominant glycosylce-
ramide isoforms produced were C:16, C:18, and C:20 fatty
chains (Fig. 3A,B). To determine whether loss of dGBA caused
any change in the activity of other lysosomal enzymes, we
also assessed hexosaminidase (Fig. 3C) and -galactosidase
(Fig. 3D). There was no age-dependent decrease in the activity
of these two enzymes in the heads of dGBA1b/ flies com-
pared with controls. Indeed, the activity of -galactosidase in
day 25 dGBA1b/ fly heads was significantly higher than in
the controls (Fig. 3D).
In addition to specific lipid defects caused by the loss of
dGBA we also looked at more general lipid abnormalities. As
mentioned above, dGBA1 is expressed in both the midgut and
the fat body of the fly, an organ analog of vertebrate adipose
tissue and liver that acts as a major organ of energy metabo-
lism and nutrient storage (Tatar et al., 2014). We therefore
assessed whether loss of dGBA in these tissues might result in
general defects in lipid metabolism. TAG is the main form of
lipid storage in the fly and therefore reflects the ability of flies
to respond to starvation conditions (Ballard et al., 2008). Mea-
surement of whole-body TAG levels in day 25 female flies
revealed a significant reduction in dGBA knock-out flies
compared with age-matched controls (Fig. 3E). In particular,
there was a greater reduction in TAG levels in double-mut-
ant dGBA1a,b/ flies compared with the single-mutant
dGBA1b/ flies (Fig. 3E). The physiological relevance of the
decrease in TAG levels was confirmed in both dGBA1b/
and, to a greater extent, in dGBA1a,b/ flies, which were
more sensitive to starvation conditions compared with con-
trols (Fig. 3F ). Furthermore, assessment of feeding behavior
by measuring proboscis-extension (Wong et al., 2009) dem-
onstrated that dGBA1b/ flies had significantly reduced feed-
ing activity compared with controls (Fig. 3G). This suggests
that reduced food intake may contribute to the reduced TAG
levels and hypersensitivity to starvation.
Loss of dGBA activity led to lysosomal-autophagic deficits
To determine whether the accumulation of the dGBA substrate
corresponds with abnormal lysosomal pathology, which is
characteristic of GD, we stained the brains of dGBA1b/
and dGBA1a,b/ flies with LysoTracker and visualized the
lysosomes with confocal microscopy. Aged dGBA1b/ and
dGBA1a,b/ flies displayed numerous enlarged and abnormal
lysosomes in their brains, which were not seen in age-matched
control brains (Fig. 4A,B). Given that normal lysosomes are re-
quired to fuse with autophagosomes to form autophagolyso-
somes in the process of autophagy (Rubinsztein et al., 2012), we
next studied autophagy. During the elongation phase, the
cytosolic form of protein microtubule-associated protein 1 light
chain 3 (LC3), LC3-I, is conjugated to phosphatidylethano-
lamine to form LC3-II, which is specifically targeted to the au-
tophagosome membrane, where it remains until fusion with
lysosomes. LC3 is therefore considered a good marker for study-
ing autophagy (Ravikumar et al., 2010). We therefore measured
the accumulation of Atg8, the fly ortholog of LC3, in both the
heads of dGBA1b/ and headless bodies of dGBA1a,b/ flies,
respectively (Fig. 5A,B).Western blot analysis demonstrated that
Atg8-I and Atg8-II accumulated in the heads of flies lacking
dGBA1b/ (Fig. 5A). Atg8-II also accumulated in the headless
bodies of flies lacking both dGBA1 genes (dGBA1a,b/) (Fig.
5B) compared with controls. Increased steady-state levels of
Atg8-II suggests increased autophagosome number, but the
marked increase in Atg8-I also could indicate a stall in flux activ-
ity in the brains of dGBA1b/ flies (Fig. 5A). Analysis of the
Atg8-II/Atg8-I ratio also confirmed increased autophagosome
formation and autophagy block in the dGBA knock-out fly heads
and bodies (Fig. 5A,B). Furthermore, Atg8 levels in homogenates
of heads from control and dGBA1b/ mutant flies demon-
strated that this tissue was unresponsive to nutrient depriva-
tion (Fig. 5A), unlike headless bodies, in which a brief 48 h
period of prior starvation slightly increased Atg8-II levels,
suggestive of autophagy induction (Fig. 5B).
p62 and polyubiquitinated proteins accumulated in
dGBA-deficient fly brains
To study the downstream effects of autophagic dysfunction, we
next performed immunostaining on the brains of dGBA-
deficient flies with antibodies against ubiquitin and p62, markers
of lysosomal-autophagic degradation (Bartlett et al., 2011). Un-
der normal physiological conditions, p62 can link ubiquitinated
proteins to the autophagy machinery (e.g., Atg8-II), targeting
them for degradation (Rogov et al., 2014). Moreover, both ubiq-
uitin and p62 accumulate when autophagy is inhibited (Bartlett
et al., 2011) and are abundant constituents of protein inclusions
associated with neurological diseases, including LBs in PD
(Zatloukal et al., 2002; Bartlett et al., 2011). We first dissected
Drosophila brains and visualized these proteins using antibodies
against polyubiquitinated proteins and the fly ortholog of p62,
Ref(2)P. Aged dGBA1b/ brains displayed elevated levels of
both ubiquitinated proteins and p62/Ref(2)P-containing aggre-
gates under the confocal microscope, which were not seen in
age-matched control fly brains (Fig. 6A). We also confirmed
elevated levels of polyubiquitinated proteins in dGBA1b/ fly
heads using Western blot analysis (Fig. 6B). Thus, dGBA
knock-out led to lysosomal-autophagic defects and the accu-
mulation of ubiquitin and p62/Ref(2)P-containing deposits in
the fly brain.
Knock-out of dGBA in the fly brain led to synaptic loss
and neurodegeneration
To study the effect of dGBA deficiency on synaptic viability, we
performed immunostaining for Bruchpilot, an essential compo-
nent of synaptic active zones in Drosophila (Wagh et al., 2006).
This revealed significantly reduced Bruchpilot in the brains of
dGBA1b/ flies compared with controls, suggesting synaptic
loss (Fig. 7A).
We also performed an ultrastructural examination of
dGBA1b/ fly brains using transmission electron microscopy.
This demonstrated grossly abnormal morphology of the omma-
tidia, the units of the compound eye, in dGBA1b/ flies com-
pared with controls (Fig. 7B). Quantitative analysis showed that
the average rhabdomere area within each ommatidium was sig-
nificantly reduced in the eyes of dGBA1b/ flies (Fig. 7B).
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Knock-out of dGBA in the brain was associated with
mitochondrial abnormalities and hypersensitivity to
oxidative stress
Ultrastructural examination of the brains of flies lacking dGBA
using electronmicroscopy revealed giant mitochondria in day 25
dGBA1b/ fly brains compared with age-matched controls (Fig.
8A) or younger day 5 dGBA1b/ brains (data not shown), with
an 25% increase in the average mitochondrial area (Fig. 8B).
The presence of giantmitochondria, in addition to the increase in
autophagy substrates and increased Atg8-II, further supported
the conclusion that there was impaired autophagic flux.
In keeping with our ultrastructural data, mitochondrial dys-
function has been shown in a mouse model of GBA deficiency
(Osellame et al., 2013) and GD human fibroblasts (de la Mata et
al., 2015). To assess mitochondrial function, we measured ATP
levels and found that they were reduced by40% in the brains of
dGBA1b/ flies as well as in thewhole bodies of dGBA1b/ and
dGBA1a,b/ flies compared with controls (Fig. 8C,D). Mito-
chondrial dysfunction can lead to decreased resistance to reactive
oxygen species, which has been implicated in many neurodegen-
erative diseases (Kinghorn et al., 2015). To explore the role of
dGBA in resistance to oxidative stress, we examined the survival
of dGBA-deficient flies after exposure to the potent oxidizer hy-
drogen peroxide (H2O2) and paraquat, a free radical generator.
Consistent with the mitochondrial abnormalities in aged flies,
day 15 dGBA1b/ and dGBA1a,b/ flies showed increased sen-
sitivity to H2O2 and paraquat stress (Fig. 8E,F).
Targeting downstream autophagy defects with the mTOR
inhibitor rapamycin
The nutrient-sensing mTOR pathway regulates lysosomal bio-
genesis and autophagy (Ravikumar et al., 2010). We hence as-
sessed the activity of mTOR by measuring the phosphorylation
level of S6K, which acts downstream of mTOR complex 1
(mTORC1) (Castillo-Quan et al., 2015). Western blot analysis
revealed a decrease in S6K phosphorylation in the heads of
dGBA1b/ flies compared with controls, indicating downregu-
lation ofmTORC1 (Fig. 9A), which would be predicted to lead to
an increase in autophagy. We also tested whether rapamycin, a
known mTORC1 inhibitor (Bjedov et al., 2010), could further
downregulate mTOR in dGBA-deficient flies. Treatment of con-
trol flies with 200 M rapamycin resulted in a
50% decrease in
S6Kphosphorylation. Therewas a trend for rapamycin treatment
of dGBA1b/ flies to further decrease S6K phosphorylation, al-
though this was not statistically significant. We therefore tested
the effect of rapamycin on the lifespan of dGBA1b/ flies. Inter-
estingly, we found that rapamycin supplementation to the fly
medium (both 200 and 400 M) from 2 d of age was able to
partially ameliorate the lifespan defect in dGBA1b/ flies (Fig.
9B). Consistent with previous work (Bjedov et al., 2010), rapa-
Figure 4. dGBA deficiency was associated with lysosomal defects. A, Brains dissected from 15-d-oldw1118 control or dGBA1b/ flies were stained with LysoTracker and imaged live within 15
min of dissection, using the same microscope settings to capture images from the same region of the subesophageal ganglion in each brain. dGBA1b/ flies displayed abnormal staining with
numerous enlarged lysosomes that were not seen in age-matched control flies. For each image, the area of LysoTracker staining above a uniform threshold was quantified, revealing a significantly
increased area of LysoTracker staining indGBA1a,b/ flies (n6experimentswith one control andonedGBA1b/brain in each experiment). **p	0.005 (paired t test).B, Similar resultswere
also seen in thebrains of 25-d-olddGBA1a,b/ flies comparedwith age-matched control flies (n6 experimentswith one control andonedGBA1a,b/brain in each experiment). **p	0.005
(paired t test).
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mycin also increased the lifespan of control flies (Fig. 9B). In
keeping with the effect on lifespan, 400 M rapamycin, but not
200 M (data not shown), was also able to partially rescue the
locomotor deficits in aged dGBA1b/ flies (Fig. 9C). An even
greater rescue was seen in flies lacking both dGBA1 genes
(dGBA1a,b/). This effect of rapamycin appeared to be specific
to dGBA knock-out flies, as rapamycin did not have a significant
effect on the climbing ability of age-matched control flies (Fig.
9C). We also assessed the effect of rapamycin on the response to
oxidative stress. Treatment with 200 M rapamycin from 2 to
15 d of age subsequently prolonged the survival of dGBA1b/
flies on food containing H2O2 (Fig. 9D). This effect was also
specific to dGBA-deficient flies, as surprisingly rapamycin-
treated control flies had reduced lifespan on exposure to H2O2
(Fig. 9D).
Rapamycin treatment is also associated with an increased
resistance to starvation in wild-type flies (Bjedov et al., 2010).
We therefore treated dGBA1b/ flies with rapamycin for the
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Figure5. Flies lacking dGBAdisplayed a block in autophagy.A,Western blot analysiswith an antibody against the fly LC 3 ortholog, Atg8, demonstrated increased levels in dGBA1b/ fly heads
compared with age-matchedw1118 control flies. Both Atg8-I and Atg8-II were increased compared with controls, and the ratio of Atg8-II/Atg8-I in dGBA1b/ flies indicated increased autopha-
gosome formation (n 3 experiments). *p	 0.05. B, Western blot analysis of Atg8 levels in the headless bodies of dGBA1a,b/ flies demonstrated no significant change in Atg8-I levels, with
an increase in Atg8-II levels and an increased Atg8-II/Atg8-I ratio. This effect was more pronounced after starvation in dGBA1a,b/ flies (n 3 experiments). *p	 0.05.
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first 15 d of adulthood before exposing them to starvation
conditions. The 200 M rapamycin was able to rescue the
survival of dGBA1b/ flies and control flies under starvation
conditions (Fig. 9E). These findings suggest that, despite the
autophagy block in flies lacking dGBA, rapamycin is still able
to exert protective effects on lifespan, locomotor defects,
and oxidative and starvation stress responses, likely by exert-
ing a small but functionally significant increase in mTOR
inhibition.
Loss of dGBA function in the brain resulted in an
upregulation ofMitf gene expression and its downstream
target gene Atg8a
To further study the effects of dGBA deficiency and rapamycin
treatment on autophagy, we measured the expression levels of
Mitf and its downstream target Atg8a. Mitf is the fly ortholog of
the mammalian transcription factor EB (TFEB) gene, the master
regulator of lysosomal biogenesis and autophagy (Bouche´ et al.,
2016; Tognon et al., 2016). TFEB is critical for the autophagic
cellular clearance of abnormal proteins and organelles, as well as
lipid metabolism. TFEB acts by coordinating the expression of a
number of genes belonging to the Coordinated Lysosomal Ex-
pression and Regulation (CLEAR) network, by directing binding
to specific CLEAR-box sequences located near their promoters.
TFEB is usually cytosolic where it interacts with mTORC1 at the
surface of the lysosome (Roczniak-Ferguson et al., 2012), but
during starvation it translocates to the nucleus where it induces
target gene transcription. Studies have shown that Mitf has
conserved regulatorymechanismswithmammalianTFEB, trans-
locating to the nucleus when Drosophila mTORC1 is inhibited
(Bouche´ et al., 2016).
We first measured Mitf gene expression in the heads of
dGBA1b/ flies. qRT-PCR data analysis showed that, in re-
sponse to the loss of dGBA activity in the brain, there is a highly
significant upregulation of Mitf gene expression (Fig. 10A). We
next studied the levels of the Atg8a gene, the fly ortholog of the
mammalian GABARAPL1 gene, which acts downstream ofMitf.
This gene is involved in themain steps of autophagosome forma-
tion and maturation. In keeping with the upregulation ofMitf in
dGBA1b/ fly heads, Atg8a was also upregulated in response to
dGBA knockdown in the fly brain (Fig. 10B).
We also studied the effect onMitf and Atg8a gene expression
of treating dGBA-deficient and control flies with 200 M rapa-
mycin from day 2 (Fig. 10A,B). Interestingly, we did not see any
increase inMitf gene expression in dGBA1b/ flies treated with
rapamycin compared with untreated flies (Fig. 10A). Moreover,
the levels of Atg8a in rapamycin-treated dGBA1b/ flies were
significantly downregulated compared with untreated flies (Fig.
10B). Rapamycin significantly increased the expression levels of
Mitf in control flies (Fig. 10A); and although there was a trend
Figure 6. dGBA-deficient flies showed accumulation of p62/Ref(2)P and polyubiquitinated proteins in their brains. A, Immunostaining with antibodies against Ref(2)P, the fly ortholog of p62,
and polyubiquitinated proteins demonstrated increased Ref(2)P- and ubiquitin-positive puncta within the dGBA1b/ fly brains. *p	 0.05 (t test). **p	 0.001 (t test). n 5 or 6 brains per
genotype. B, Western blotting of Triton-insoluble head extracts confirmed the presence of significantly increased levels of polyubiquitinated proteins in dGBA1b/ flies. **p	 0.05. n 4
samples per genotype, 10–15 heads per sample.
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toward increasing Atg8a levels, it was not statistically significant
(Fig. 10B). Thus, loss of dGBA activity in the brain is associated
with increased expression levels ofMitf, and its downstream tar-
get gene, Atg8a, but upregulation of Mitf expression is not re-
sponsible for the protective effect of rapamycin on lifespan,
locomotor, and oxidative stress phenotypes.
Discussion
We generated a Drosophilamodel of neuronopathic GD. Simple
genetics could not be used to precisely excise both Drosophila
GBA1 genes, dGBA1a and dGBA1b, due to the presence of the
CG31413 gene between them. Therefore, we used serial homolo-
gous recombination to knock out both dGBA1 genes separately
or together in the fly. Of the two fly GBA orthologs, only dGBA1b
is expressed in the fly brain (Flyatlas). dGBA1b/ fly heads, lack-
ing dGBA1b expression, displayed accumulation of the dGBA
substrate glucosylceramide. Furthermore, the glucosylceramide
isoforms (C16:0, C18:0, C22:0) were similar to those found in
human spleen tissue (with the addition of hydroxylated or longer
chain isoforms including C18:0-OH, C20:0-OH, C24:1, and
C24:0 in the human tissue (N. Sebire and S. Paine, unpublished
data). Moreover, this is consistent with data showing accumula-
tion of glucosylceramide and glucosylsyphingosine in Types II
and III GD patient brains (Orvisky et al., 2002).
Abnormally engorged lysosomes in dGBA1b/ fly brains
were visualized with LysoTracker, confirming the validity of this
neuronopathicGD flymodel. Lysosomal integrity is necessary for
normal functioning of the autophagy degradation machinery
(Xu and Ren, 2015), and accordingly we observed autophagy
dysfunction in dGBA1b/ brains, with accumulation of the au-
tophagolysosomal protein Atg8/LC3. Thus, we demonstrate au-
tophagy defects at the level of the autophagicmachinery in vivo in
a GDDrosophilamodel, following on from in vitro studies in GD
macrophages and iPSCs showing impaired autophagy (Awad et
al., 2015; Aflaki et al., 2016; Fernandes et al., 2016).
Neuronal-specific autophagy deficits, through loss of the
mouse autophagy genes atg7 or atg5, result in accumulation of
polyubiquitinated proteins, behavioral defects, and reduced lon-
gevity (Hara et al., 2006; Komatsu et al., 2006). Consistent with
this, we found that dGBA1b/ flies displayed reduced survival
and locomotor ability and brain accumulation of p62/Ref(2)P
andpolyubiquitinated proteins. Both p62 andubiquitin accumu-
late in neurodegenerative diseases, such as Alzheimer’s disease
and PD (Zatloukal et al., 2002; Bartlett et al., 2011), and multiple
pathogenic proteins, including p62 and -amyloid, have been
identified in neuronopathic GD mouse brains (Xu et al., 2014).
Surprisingly, knock-out of dGBA1a, which is predominantly
expressed in the digestive system, significantly increased survival.
This finding parallels recent research in Drosophila and Caeno-
rhabditis elegans demonstrating that the intestine is an important
target organ for mediating lifespan extension at the organismal
Figure 7. Deficiency of dGBA resulted in synaptic loss and neurodegeneration.A, Immunostaining for Bruchpilot (brp), a critical synaptic component, demonstrated reduced staining (red) in the
brains of day 25dGBA1b/ flies comparedwith controls. Antennal lobe (AL) and suboesphageal (SOG).n7–8brains per genotype.B, EMof the eyes of day 25dGBA1b/ flies revealedgrossly
abnormalmorphology of the ommatidia comparedwith age-matched controls (5600). Scale bars, 2m. In addition, quantitative analysis revealed a reduction in average rhabodomere (*) area
in dGBA1b/ fly eyes (***p 4 106; at least 80 consecutive rhabdomeres studied for each genotype).
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level, with single-gene manipulations specifically in the gut pro-
longing lifespan (Rera et al., 2011; Tatar et al., 2014). The role of
dGBA in the gut in regulating lifespan was beyond the scope of
this study but is an area that warrants further investigation. We
demonstrated, however, that the lifespan extension seen in
dGBA1a/ flies is not associated with any improvement in lo-
comotor ability.
Mitochondrial integrity is necessary for normal autophagy-
lysosomal system functioning (Palikaras and Tavernarakis, 2012;
Ashrafi and Schwarz, 2013). Indeed, mitochondrial dysfunction
occurs in GD mouse models (Osellame et al., 2013; Xu et al.,
2014), likely due to defects in the autophagic removal of damaged
mitochondria (Osellame et al., 2013). In keeping with this, the
deficiency of the Drosophila autophagy gene atg7 is associated
with sensitivity to oxidative stressors (Juha´sz et al., 2007).
Accordingly, we demonstrated mitochondrial abnormalities
in dGBA1b/ flies, with giant mitochondria, reduced ATP
and hypersensitivity to oxidative stress. Enlarged mitochon-
dria and decreased ATP occur in neuronopathic GD mice (Xu
et al., 2014), and giant mitochondria are directly linked to
Drosophila autophagy defects (Bouche´ et al., 2016). Therefore,
the accumulation of autophagic substrates and giant mito-
chondria in dGBA1b/ flies is consistent with autophagy
block (Fig. 10C).
Figure 8. dGBA-deficient fly brains displayed mitochondrial abnormalities. A, EM analysis of the brains of day 25 dGBA1b/ flies showed giant mitochondria (arrows) compared with
mitochondria (arrows) in age-matchedw1118 control fly brains (11,500magnification). Scale bar, 1m.B, Averagemitochondrial areawas increased in dGBA1b/ flies (n
 200mitochondria
per genotype). ***p 4 105. C, Thesemitochondrial structural abnormalitieswere associatedwith decreased ATP levels in day 25 dGBA1b/ fly heads (**p 0.0016) and (D) in thewhole
bodies ofdGBA1b/ flies comparedwithage-matched controls (*p0.02). Therewasa trend for reducedATP levels in thedGBA1a,b/ flies, but this didnotquite reach significance ( p0.06).
E,dGBA1b/anddGBA1a,b/ flies displayed reduced survival onexposure to5%H2O2 ( p310
12 andp51015) and (F ) 20mMparaquat ( p0.003andp2106;n150
flies per genotype).
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Furthermore, we demonstrated that the neuropathological
defects in dGBA1b/ flies occur independently of -synuclein,
confirming that dGBA deficiency is sufficient to cause neurode-
generation (Fig. 10C). A recent study using a deletion mutant
harboring imprecise removal of the dGBA1b gene, as well as the
incomplete removal of the dGBA1a gene and excision of the in-
terjacentCG31413 gene, provides further validation of ourmodel
for studyingGBA1-associated neurodegeneration. Loss of 60%of
GCase activity was also associated with reduced survival and
climbing ability in addition to accumulation of autophagy sub-
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Figure 9. The mTOR inhibitor rapamycin partially ameliorated the lifespan, locomotor, oxidative stress, and starvation phenotypes in dGBA-deficient flies. A, Day 7 dGBA1b/ fly heads had
significantly decreased phosphorylated S6K (p-S6K) levels compared with age-matched control flies. *p 0.0414. Treatment of control flies with 200 M rapamycin led to a reduction in
phospho-S6K levels. ***p0.0009. Although therewas a trend for rapamycin to further decreasephospho-S6K levels indGBA1b/ flies, thiswasnot statistically significant ( p0.327, one-way
ANOVA with Bonferroni correction). B, The 200 and 400M of rapamycin significantly extended the lifespan of dGBA1b/ flies ( p 0.005 and p	 0.05; n 110–160 flies per genotype and
condition). Aspreviously demonstrated, rapamycin also extended the lifespanofw1118 control flies ( p0.007andp0.02).C, Treatmentwith400M rapamycinpartially rescued theage-related
climbing defects in day 35 dGBA1b/ flies and dGBA1a,b/ flies (***p 0.0005 and ***p 0.0006), but did not have a significant effect on the climbing ability of age-matched control flies
( p0.23;n45 flies pergenotypeandcondition, averageof 3 repeats).D, TreatmentofdGBA1b/ flies from2 to15dof agewith200M rapamycinpartially rescued the survival on subsequent
exposure to food containing 5% H2O2 ( p 2.5 10
9). This protective effect was specific to dGBA-deficient flies as 200M rapamycin was toxic to control flies under similar conditions ( p
0.0007; n 60 flies per group). E, The 200M rapamycinwas also able to increase survival of dGBA1b/ flies in response to subsequent exposure to starvation conditions from 15 d of age. *p
0.004. The time point shown is after 3 d of starvation stress (n 60 flies per condition). Under similar conditions, 200M rapamycin also rescued the survival of controlw1118 flies (n 60 flies per
group). *p 0.023. The bar chart represents survival after 8 d of exposure to starvation.
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strates (Davis et al., 2016). GCase deficiency was also shown to
enhance -synuclein pathology in the fly (Suzuki et al., 2015;
Davis et al., 2016). Our model has the advantage over existing
models, as it allows the precise and complete knock-out of each of
the dGBA genes, and the dissection of the role of dGBA in differ-
ent tissues. The ability to knock out only brain-specific dGBA1b is
particularly relevant given our finding that loss of dGBA in the
gut causes prolongevity effects. Our model also avoids the pro-
duction of truncated, possibly pathogenic, variants of dGBA.
The nutrient-sensing mTOR is localized to the lysosomal sur-
face (Efeyan et al., 2012; Betz andHall, 2013), where it modulates
autophagy (Yu et al., 2010; Zoncu et al., 2011). It has thus been
speculated that abnormal lysosomal function leads to activation
of autophagy by mTOR downregulation (Li et al., 2013). Indeed,
a recent study reported increased expression of mTOR signaling
pathway genes in neuronopathic GD mice (Dasgupta et al.,
2015). In view of the autophagy defect in dGBA1b/ flies, we
probedmTOR signaling by analyzing S6K phosphorylation dow-
nstreamofmTORC1. Interestingly, we detected a decrease in S6K
phosphorylation and hence downregulation of mTORC1 com-
pared with controls. Furthermore, although not statistically sig-
nificant, therewas a trend formTOR to be further downregulated
in dGBA1b/ flies treated with rapamycin, a known mTORC1
inhibitor. Because rapamycin has protective effects in animal
Figure 10. Knock-out of dGBA activity in the fly brain was associated with upregulation ofMitf and its downstream target Atg8a. A, qRT-PCR data analysis revealed that day 15 dGBA1b/ fly
heads had increased expression levels ofMitf compared with controls. ***p 9.7 105. In addition, treatment with 200M rapamycin from 2 d of age had no significant effect onMitf gene
expression in dGBA1b/ flies ( p 0.32). However, rapamycin treatment led to a significant increase in the expression levels ofMitf in control flies (**p 0.016).B,Atg8a gene expression levels
were greater in dGBA1b/ fly heads comparedwith controls. ***p 2.8 107. Treatmentwith 200M rapamycin resulted in a decrease inAtg8agene levels in dGBA1b/ fly heads (**p
0.002); and although therewas a trend toward increasedAtg8a gene expression in control flieswith rapamycin treatment, it did not reach statistical significance ( p 0.054). ThemRNA expression
levels of all genes are shown relative to the expression levels of a control gene, RP49. C, Schematic diagram showing the downstream effects of impaired autophagy flux in dGBA-deficient flies.
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models of PD and other neurodegenerative diseases (Malagelada
et al., 2010; Cheng et al., 2015), we treated dGBA1b/ flies with
rapamycin and found that, despite the autophagy block, it was
able to partially ameliorate many neurotoxic phenotypes. Rapa-
mycin treatment led to an improvement in the lifespan and
climbing phenotypes, in addition to the hypersensitivity to oxi-
dative and starvation stressors seen in dGBA1b/ flies. These
results are somewhat surprising given that rapamycin treatment
of iPSC-derived neuronal cells from GD patients caused cell
death (Awad et al., 2015), demonstrating that drug effects in vitro
vary to those at the organismal level. Furthermore, although
rapamycin increases the lifespan and protects against starvation
conditions in control flies (Bjedov et al., 2010), the rescue of
age-related climbing defects and oxidative stress appeared to be
specific to dGBA-deficient flies. Indeed, rapamycin had no effect
on the climbing ability of control flies, and rapamycin-treated
control fliesweremore sensitive toH2O2 thanuntreated flies. The
reason for the opposing effects of rapamycin on the oxidative
stress responses of dGBA1b/ and control flies is unclear, but
may be related to the differential activation of oxidative stress
pathways between dGBA1b/ and healthy controls.
Lastly, we demonstrated that knock-out of dGBA in the brain
results in an upregulation of Mitf and its downstream target,
Atg8a, suggesting a compensatory response to the autophagy
block. This is in contrast to findings in a recent study showing
downregulation of TFEB expression in GD iPSC-derived cells
(Awad et al., 2015). The reasons for these differing results is not
clear, but possible explanations may relate to variations in au-
tophagy block between models, and the fact that neuronal cells
are newly differentiated and may reflect early disease compared
with adult flies. Mitf gene expression may also vary in the pres-
ence of mutant dGBA. Our fly model displays very little dGBA
expression compared with iPSC cells, which are derived from
mutant carriers, and therefore, despite showing very low levels of
GCase activity, express mutant GBA. Mutant GCase is known to
exert gain-of-function toxic effects, including inDrosophila, with
upregulation of the unfolded protein response (Maor et al., 2013,
2016). Knockdown ofMitf in Drosophila leads to similar pheno-
types to those in dGBA1b/ flies, including autophagy substrate
accumulation, upregulation of Atg8-II, giant mitochondria, as
well as enlarged lysosomes (Bouche´ et al., 2016). Thus, the au-
tophagy defects seen in dGBA deficiency appear to phenocopy
Mitf downregulation in the fly. This suggests that upregulating
Mitf as a potential therapeutic strategy inGDandGBA-linked PD
may be limited in its efficacy due to the inability of GBA-deficient
neuronal tissue to stimulate autophagy. Further studies are war-
ranted to explore the complex interaction betweenmTORC1 and
TFEB/Mitf in GD.
Rapamycin treatment of dGBA1b/ flies did not upregulate
Mitf gene expression, suggesting that rapamycin does not act
through Mitf signaling to rescue the neurotoxic phenotypes of
dGBA-deficient flies. We hypothesize, therefore, that mTOR is
downregulated in dGBA-deficient flies as a compensatory response
to lysosomal-autophagy block. Possibly as a consequence of lyso-
somal dysfunction in dGBA-deficient flies, the normal interaction
between mTORC1 and TFEB/Mitf at the surface of the lysosome is
disrupted, leading to changes in TFEB/Mitf gene expression. There-
fore, by exerting small additional effects on mTORC1 signaling,
rapamycin may mediate its beneficial effects (Fig. 10C). Further-
more,Mitf also plays a critical role in lipid metabolism and recapit-
ulates the functionofTFEB inmammals in this regard(Bouche´ et al.,
2016).Mitf expressionmay therefore contribute to the reducedTAG
that we see in dGBA1b/ flies.
In conclusion, the autophagy defects seen in our GD flies,
likely as a result of failure of the fusion of autophagosomes and
lysosomes,may also be relevant to PD linked toGBA1mutations.
Our results raise the possibility that therapies aimed at amelio-
rating not only lysosomal dysfunction, but also at autophagic
abnormalities, including lowering mTOR activity, may be effec-
tive in treating GBA1-associated disease. They also suggest that
rapamycinmay offer significant health benefits in neuronopathic
GD and in GBA1-related synucleinopathies. Together, our data
demonstrate that these Drosophila models of dGBA-deficiency
are a useful platform to further study the downstream effects of
lysosomal-autophagic dysfunction and to identify genetic modi-
fiers and new therapeutic targets in neuronopathic GD and
GBA1-associated PD.
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